ZNF416 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.418200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.069400E-01
Normal-vs-Stage2
3.906200E-02
Normal-vs-Stage3
6.546300E-02
Normal-vs-Stage4
9.441600E-01
Stage1-vs-Stage2
4.004200E-01
Stage1-vs-Stage3
2.687400E-01
Stage1-vs-Stage4
5.065800E-01
Stage2-vs-Stage3
3.677200E-01
Stage2-vs-Stage4
1.321540E-02
Stage3-vs-Stage4
2.306100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.120400E-02
Normal-vs-AfricanAmerican
9.150400E-02
Normal-vs-Asian
1.238050E-01
Caucasian-vs-AfricanAmerican
5.712000E-01
Caucasian-vs-Asian
6.036200E-01
AfricanAmerican-vs-Asian
8.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.697800E-02
Normal-vs-Female
1.145420E-01
Male-vs-Female
2.515200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.476200E-01
Normal-vs-Age(41-60Yrs)
2.402600E-01
Normal-vs-Age(61-80Yrs)
3.366200E-02
Normal-vs-Age(81-100Yrs)
5.084100E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.629800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.544200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.615200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.278200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.042000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.642200E-03
Normal-vs-Daily Drinker
4.885900E-02
Normal-vs-Weekly Drinker
5.054400E-02
Normal-vs-Occasional Drinker
4.596800E-01
Normal-vs-Social Drinker
5.717700E-02
Non Drinker-vs-Daily Drinker
1.909210E-01
Non Drinker-vs-Weekly Drinker
1.338750E-01
Non Drinker-vs-Occasional Drinker
1.6452699999947E-05
Non Drinker-vs-Social Drinker
7.999900E-03
Daily Drinker-vs-Weekly Drinker
8.072200E-01
Daily Drinker-vs-Occasional Drinker
4.802700E-03
Daily Drinker-vs-Social Drinker
2.407200E-01
Weekly Drinker-vs-Occasional Drinker
1.232400E-02
Weekly Drinker-vs-Social Drinker
3.497400E-01
Occasional Drinker-vs-Social Drinker
5.442300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.614400E-01
Normal-vs-Grade 2
9.362600E-01
Normal-vs-Grade 3
9.291800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.926600E-01
Grade 1-vs-Grade 3
3.468400E-01
Grade 1-vs-Grade 4
6.614400E-01
Grade 2-vs-Grade 3
8.810600E-01
Grade 2-vs-Grade 4
9.362600E-01
Grade 3-vs-Grade 4
9.291800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.375700E-03
Normal-vs-NonDiabetic
1.187760E-01
Diabetic-vs-NonDiabetic
8.942400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.305800E-02
Normal-vs-NoPancreatitis
7.746500E-02
Pancreatitis-vs-NoPancreatitis
5.400000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.654000E-02
Normal-vs-N1
5.086000E-02
N0-vs-N1
6.770600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.130600E-01
Normal-vs-TP53-NonMutant
2.457800E-01
TP53-Mutant-vs-TP53-NonMutant
4.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
